Cite
HARVARD Citation
Clamp, A. et al. (n.d.). Effect of progression-free interval (PFI) following penultimate platinum-based regimen on the efficacy of rucaparib maintenance treatment in patients with platinum-sensitive, recurrent ovarian carcinoma: an analysis from the phase 3 study ARIEL3. International journal of gynecological cancer. pp. A27-A28. [Online].